ArticleJournal of clinical and experimental hematopathology : JCEH2022

Addition of bortezomib to high-dose cyclophosphamide therapy as a conditioning regimen for autologous peripheral blood stem cell harvest leads to an increased yield of hematopoietic stem cells.

Sayaka Ohno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.